CRC therapies involve surgery, chemotherapy, and emerging targeted biological therapies against specific molecular targets, such as anti-epidermal growth factor receptor (EGFR) and anti-vascular endothelial growth factor (VEGF). Here, VEGFA is linked to colorectal carcinoma.